New approach attempts to rescue failed gout treatment
NCT ID NCT06186219
Summary
This small safety study tested whether giving rituximab before standard gout treatment could help patients who previously stopped responding to pegloticase. The research involved just 2 adults with severe, tophaceous gout that wasn't controlled by other medications. Doctors wanted to see if rituximab pretreatment could help these patients respond again to the standard combination of methotrexate and pegloticase.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TOPHACEOUS GOUT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UCLA
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.